Peptide-based Cancer Therapeutics Market Size, Forecast to 2035

The global peptide-based cancer therapeutics market refers to the pharmaceutical industry focused on using therapeutic peptides to treat cancer. There is an upsurge in the development of therapeutic peptides for a wide range of diseases, especially cancer. They are preferably used over antibiotics, radiation therapy, and chemotherapy owing to their flexibility, easy modification, low immunogenicity, and inexpensive production cost. Innovation and market expansion are anticipated as a result of major players\' growing R&D expenditures and expanding partnerships. For instance, in January 2025, AbbVie announced that it had completed its acquisition of Nimble Therapeutics to strengthen AbbVie’s pipeline and R&D capabilities. Furthermore, the quick development of novel therapeutic vaccines by the use of the power of multi-epitope peptides is driving a huge surge in the global peptide-based cancer therapeutics market.